联系我们
    
     电    话:0771-2310996
     传    真:0771-2310995 
     E-mail : 735565094@qq.com  
     技术支持E-mail: immunechem@gmail.com   备案号:桂ICP备09007987号
     地    址:广西南宁市高新技术开发区科园大道68号东盟慧谷11栋203室 530007
    
    
    
    
  
| Catalog# Product Description | ICP0705 This high affinity anti-HA antibody is developed using HA peptide (YPYDVPDYA) conjugated to KLH and affinity-purified with the HA peptide. The antibody is useful for detection, isolation and localization of the HA-tag proteins. |  |   
						Western-blot analysis of the HA-tag protein (50 kd) expressed cell lysate and  affinity enriched by IP,  with HA-tag antibody, HRP conjugates (ICP0751) 1: Molecular marker 2: 10 uL of HA-tag protein in lysate (original cell lysate) 3: 10 uL of His-tag protein in lysate (after IP depletion)  4: 10 uL of the HA-tag protein in 100 uL of the eluting buffer enriched with 25 ug of the anti-His tag (ICP0750) from 2 mL of the original lysate. 
					   
						Western blot analysis of the cell extract with expression of HA-tag proteins (B-F) and without expression of HA (A). 
					 | 
| 
						Species 
					 | 
						Rabbit 
					 | ||
| 
						Formulation 
					 | 
						500 µg/mL in PBS, 50% glycerol 
					 | ||
| 
						Immunogen 
					 | 
						GST peptide EEHLYERDEGDKWR KLH conjugates 
					 | ||
| 
						Purification 
					 | 
						Antigen-specific affinity chromatography 
					 | ||
| 
						Specificity 
					 | 
						The antibody recognizes HA-tag proteins. 
					 | ||
| 
						Applications 
					 | 
						ELISA (1:2500); WB (1:1000); IP (5 µg/sample) 
					 | ||
| 
						Scientific Description 
					 | 
						Hemaglutinin peptide (HA) is frequently used as an affinity tag to facilitate the detection, isolation and localization of the HA-fusion proteins. 
					 | ||
| 
						Storage & Stability 
					 | 
						Product is stable for several weeks at 4°C. For extended storage, store product at -20°C.Expiration date is one year from date of shipping if stored properly. 
					 | ||
| 
						Product Specific References 
					 | 
						1. Cancer Res. 2010. 70: 10445.doi: 10.1158/0008-5472.CAN-10-3040 
					 | 

 
    

